Biochem/physiol Actions
Reversible: yes
Product does not compete with ATP.
Primary TargetAβ40 in vitro
Target IC50: 7.9 µM for Aβ40; 7.6 µM for Aβ42 in vitro
Cell permeable: yes
General description
A cell-permeable, reversible dipeptide aldehyde that reduces amyloid-β protein (Aβ) production by blocking γ-secretase activity in vitro (Aβ40 IC50 = 7.9 µM; Aβ42 IC50 = 7.6 µM) and in cultured cells that stably over-express APP695 (Aβ40 IC50 = 11.5 µM; Aβ42 IC50 = 8.3 µM). Also shown to block the generation of γCTF (γ-secretase-generated carboxy-terminal fragment).
A cell-permeable, reversible dipeptide aldehyde that reduces Aβ production by blocking γ-secretase activity in vitro (Aβ40 IC50 = 7.9 µM; Aβ42 IC50 = 7.6 µM) and in cultured CHO 2b-7 cells that stably overexpress APP695 (Aβ40 IC50 = 11.5 µM; Aβ42 IC50 = 8.3 µM). Also blocks the generation of CTFγ (γ-secretase-generated carboxyl-terminal fragment). Does not affect the formation of amyloid-β-precursor protein (APP).
Legal Information
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
Other Notes
Weijzen, S., et al. 2002. Nat. Med.8, 979.McLendon, C., et al. 2000. FASEB J.14, 2383.
Packaging
Packaged under inert gas
5 mg in Plastic ampoule
Sequence
Z-Ile-Leu-CHO
Warning
Toxicity: Standard Handling (A)
This product has met the following criteria to qualify for the following awards: